STRATA Skin Sciences (NASDAQ:SSKN) Now Covered by Analysts at Maxim Group

Research analysts at Maxim Group assumed coverage on shares of STRATA Skin Sciences (NASDAQ:SSKN) in a research note issued on Thursday,Benzinga reports. The brokerage set a “buy” rating and a $6.00 price target on the medical device company’s stock. Maxim Group’s target price suggests a potential upside of 122.22% from the stock’s previous close.

STRATA Skin Sciences Trading Up 1.1 %

Shares of SSKN traded up $0.03 during midday trading on Thursday, hitting $2.70. The stock had a trading volume of 306 shares, compared to its average volume of 4,060. STRATA Skin Sciences has a fifty-two week low of $2.51 and a fifty-two week high of $6.00. The business has a 50-day simple moving average of $2.88 and a two-hundred day simple moving average of $2.97. The firm has a market cap of $11.26 million, a P/E ratio of -1.02 and a beta of 1.33. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.